Source: Υπουργείο Υγείας (CY) Revision Year: 2018 Publisher: Remedica Ltd, Aharnon Street, Limassol Industrial Estate, 3056 Limassol, Cyprus
Alfoxan 250 mg hard capsules.
| Pharmaceutical Form |
|---|
|
Hard capsules. Light blue/ivory capsules. |
Each hard capsule contains 250 mg mefenamic acid.
Excipient(s) with known effect:
This product contains 64.9 mg lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Mefenamic acid |
Mefenamic acid is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic properties. |
| List of Excipients |
|---|
|
Capsule content: Povidone Capsule shell: Quinoline yellow E104 |
PVC/Aluminium blisters. Pack sizes of 20, 100 and 1000 hard capsules.
PP containers with PE closure. Pack sizes of 100, 500 and 1000 hard capsules.
Not all pack sizes may be marketed.
Remedica Ltd, Aharnon Street, Limassol Industrial Estate, 3056 Limassol, Cyprus
19924
Date of first authorization: 29 December 2005
Date of latest renewal: 11 June 2012
| Drug | Countries | |
|---|---|---|
| ALFOXAN | Cyprus, Hong Kong, Malta, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
